Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Daiwa Pharmaceutical
Setagaya-ku, Tokyo, Japandaiwa-pharm.com ↗
- Ownership
- Private
- Employees
- ~30
- Development stage
- Other
01
Overview
Daiwa Pharmaceutical develops and commercializes functional food ingredients such as BioBran (rice bran arabinoxylan compound), NKCP (nattokinase-based product), and Rice Kefiran. These are distributed in over 50 countries for immune modulation, cardiovascular health, and gut health. The company’s products are supported by accumulated research including human clinical studies for some ingredients[1][4][5].
- Therapeutic areas
- ImmunologyCardiovascularOther
- Modalities
- Small moleculeBiologicMicrobial therapyPrebioticPostbiotic
- Industry
- Food & Nutrition
Beyond the preview
Go deeper on Daiwa Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Daiwa Pharmaceutical.